statistiche ricercatore

Continente	#
AS - Asia	942
NA - Nord America	690
EU - Europa	384
SA - Sud America	50
Continente sconosciuto - Info sul continente non disponibili	48
AF - Africa	45
OC - Oceania	1
Totale	2.160

Nazione	#
US - Stati Uniti d'America	666
VN - Vietnam	326
CN - Cina	201
SG - Singapore	201
IT - Italia	132
DE - Germania	55
SE - Svezia	50
KR - Corea	42
HK - Hong Kong	41
BD - Bangladesh	39
BR - Brasile	36
NL - Olanda	32
IN - India	29
FI - Finlandia	19
FR - Francia	17
GB - Regno Unito	17
JP - Giappone	16
CI - Costa d'Avorio	14
IE - Irlanda	14
CA - Canada	13
PH - Filippine	10
SC - Seychelles	10
TG - Togo	10
RU - Federazione Russa	8
TH - Thailandia	8
AT - Austria	7
CH - Svizzera	7
BG - Bulgaria	6
JO - Giordania	6
IQ - Iraq	5
MX - Messico	5
AR - Argentina	4
ID - Indonesia	4
LT - Lituania	4
NG - Nigeria	4
SA - Arabia Saudita	4
ZA - Sudafrica	4
PL - Polonia	3
UA - Ucraina	3
VE - Venezuela	3
ES - Italia	2
HR - Croazia	2
JM - Giamaica	2
PK - Pakistan	2
SK - Slovacchia (Repubblica Slovacca)	2
TR - Turchia	2
UY - Uruguay	2
AE - Emirati Arabi Uniti	1
AO - Angola	1
AU - Australia	1
BE - Belgio	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
GR - Grecia	1
HN - Honduras	1
IL - Israele	1
IS - Islanda	1
KE - Kenya	1
OM - Oman	1
PE - Perù	1
PS - Palestinian Territory	1
PY - Paraguay	1
SN - Senegal	1
SV - El Salvador	1
SX - ???statistics.table.value.countryCode.SX???	1
TW - Taiwan	1
UZ - Uzbekistan	1
Totale	2.113

Nome	#
Pattern of macrovascular invasion in hepatocellular carcinoma	244
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study	243
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs	242
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study	228
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites	217
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry	200
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination	196
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort	170
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection	146
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis	123
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study	93
Neutrophil–lymphocyte ratio is associated with worse outcomes in patients with cirrhosis: insights from the PRO-LIVER Registry	58
Totale	2.160

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	159	0	0	5	13	20	8	3	9	5	11	65	20
2022/2023	180	15	33	8	24	12	19	3	9	26	4	13	14
2023/2024	91	2	16	8	4	7	13	1	24	4	8	0	4
2024/2025	365	17	33	23	26	45	25	25	14	9	41	46	61
2025/2026	1.229	98	106	82	82	66	33	198	61	213	110	68	112
2026/2027	48	35	13	0	0	0	0	0	0	0	0	0	0
Totale													2.160

CRIS Current Research Information System